A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma.

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma.

Stadler WM, Rybak ME, Vogelzang NJ. A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma. Cancer. 1995 Nov 01; 76(9):1629-33.

View in: PubMed

subject areas

Adult
Aged
Carcinoma, Renal Cell
Enzyme-Linked Immunosorbent Assay
Female
Humans
Injections, Subcutaneous
Interleukin-4
Kidney Neoplasms
Male
Middle Aged
Neoplasm Metastasis
Prognosis
Receptors, IgE
Recombinant Proteins
Solubility

authors with profiles

Walter M. Stadler